ELV Elevance Health
Permanent stock page ↗Health Care · S&P 500
Next earnings: Thu 28 Jan 2027 · estimated
What 24 analyst firms say about Elevance Health: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
22 rated views · 24 analyst/firm records · 24 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8060
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8070
Recent analyst activity · last 90 days
Our tracked history has 22 reports on ELV from 18 analyst firms in the last 90 days (25 firms in the past year).
Comparing each firm's latest target with its previous one: 14 raised their price target and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wells Fargo raised its target from $473.00 (set 16 Jul 2026) to $492.00 on 26 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Hold | 21 Aug 2026 | — |
| Baird | Michael Ha | Hold | 22 Oct 2026 | 406.00 USD |
| Bank of America Securities | Kevin Fischbeck | Buy | 4 Jun 2026 | 460.00 USD |
| Barclays | Andrew Mok | Buy | 22 Oct 2026 | 472.00 USD |
| Bernstein | Lance A Wilkes | Buy | 22 Oct 2026 | 520.00 USD |
| Cantor Fitzgerald | Sarah James | Buy | 22 Oct 2026 | 493.00 USD |
| Citigroup | Unnamed analyst | Buy | 29 Apr 2026 | — |
| Deutsche Bank | George Hill | Buy | 20 May 2026 | 498.00 USD |
| Evercore ISI | Elizabeth Anderson | Hold | 5 Oct 2026 | Conflicting reports · excluded |
| Goldman Sachs | Scott Fidel | Hold | 23 Oct 2026 | 451.00 USD |
| Guggenheim | Jason Cassorla | Buy | 22 Oct 2026 | 485.00 USD |
| Jefferies | David H Windley | Buy | 22 Oct 2026 | 510.00 USD |
| JPMorgan | Lisa Gill | Buy | 8 Jun 2026 | 476.00 USD |
| Leerink Partners | Whit Mayo | Hold | 22 Oct 2026 | 450.00 USD |
| Mizuho | Ann Hynes | ConflictConflicting reports · excluded | 23 Oct 2026 | 490.00 USD |
| Morgan Stanley | Erin Wright | Hold | 22 Oct 2026 | 449.00 USD |
| RBC Capital Markets | Ben Hendrix | Hold | 22 Oct 2026 | 455.00 USD |
| TD Cowen | Ryan Langston | Buy | 23 Oct 2026 | 495.00 USD |
| Truist | David S Macdonald | Buy | 22 Oct 2026 | 500.00 USD |
| UBS | A.J. Rice | Buy | 22 Oct 2026 | 523.00 USD |
| Weiss Ratings | Unnamed analyst | — | 13 Aug 2026 | — |
| Wells Fargo | Stephen Baxter | Buy | 27 Oct 2026 | 492.00 USD |
| Wolfe Research | Justin Lake | Buy | 23 Jun 2026 | 463.00 USD |
| Data feed RESEARCH | Research Team | Hold | 7 May 2026 | 451.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:24 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.